America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
During recessions, some index funds fare better than others. This intro highlights selection criteria and defensive positioning.
25,743 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
TriSalus investors are eyeing the Q1 2026 earnings update to gauge cash runway, pipeline progress, and milestone-driv...
Bitcoin ETFs pulled about $2 billion in net inflows in April, the strongest monthly total so far this year. May opene...
A new AI-driven forecast links regulatory resolution, ETF uptake, and RippleNet expansion to a potential XRP surge to...
A high-profile market commentator signals a pullback may be on the horizon, even as AI-driven gains keep major indice...
High-profile legal headlines can ripple into everyday money matters. This article uses the James Harden case to illus...
A long-standing IRS provision lets parents transfer tuition and certain medical payments directly to institutions wit...
Morgan Stanley says the strait hormuz reopening faster is easing supply fears, prompting a downgrade of its oil-price...
Apple’s board approved a fresh $100 billion buyback as Q2 2026 results beat expectations, underscoring the tech giant...
Consensys says a third-party contractor linked to North Korea accessed MetaMask code for roughly a month before acces...
A 2026 wave of disclosures shows universities reevaluating ties to Jeffrey Epstein’s fundraising network, prompting r...
OpenAI’s Sam Altman apologized for sloppy wording in announcing a Pentagon contract, pledging a revised release to em...